Skip to main content

Table 3 Correlations between CXCL8 expression and clinic-pathological features of 75 ADC patients in immunohistochemistry chip (HLug-Ade150Sur-02)

From: DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis

Variables

N

CXCL8 expression

P value

≤ 8 (low expression)

> 8 (high expression)

Age

   

0.865a

 < 55

20

14

6

 

 ≥ 55

53

36

17

 

Sex

   

0.255a

 Male

40

30

10

 

 Female

35

22

13

 

Grade

   

0.249b

 1~ 2

61

40

21

 

 3

14

12

2

 

Stage

   

0.024a

 I~II

40

30

10

 

 III

18

8

10

 

Lymph node

    

 N−

36

29

7

0.004a

 N+

21

9

12

 

Tumor size

    

 T1–T2

60

45

15

0.069b

 T3–T4

15

7

8

 
  1. aPearson chi-square test
  2. bContinuity correction chi-square test